7.08
-0.98%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Xiangcai Co
Its shares trade on Shanghai under the ticker 600095.SS. It has been listed since 8 July 1997. In the fiscal year to 31 December 2025, it reported net income of CN¥464.1m. At that date it held total assets of CN¥44.04bn and shareholders' equity of CN¥12.26bn.
Xiangcai Co., Ltd. engages in the businesses of non-GMO soybean products processing, pharmaceuticals, waterproof membrane, and industrial plants. The company is headquartered in Harbin, Heilongjiang. The firm is also involved in soybean deep processing, pharmaceutical production and waterproofing membrane manufacturing and sales businesses. Its real estate business is engaged in residential and industrial real estates development business, as well as property management business. Its soybean deep processing business provides soybean protein isolate, soybean tissue protein and soybean nutritious food. Its pharmaceutical business is mainly engaged in the production and marketing of thymopeptide enteric-coated tablets and other drugs for the treatment of immune system. Its waterproof coil business is engaged in the manufacture and sales of polyethylene polypropylene fiber coils, load-bearing coil and joint profiles.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Real Estate
- Industry
- Real Estate Management & Development
- Listed since
- 8 Jul 1997
- Employees
- 2,115
- Website
- 600095.com.cn ↗
Leadership
Pay as last reported
- Mr. Jianming ShiChairman of the Board, President, since 2018CN¥2.0m
- Mr. Haidong ChengFinance Director, Vice President, Director, since 2022
- Mr. Jianyao ChaiVice PresidentCN¥900,000
- Mr. Bohan LingVice President
- Ms. Qiong PanSecretary of the BoardCN¥400,000
- Mr. Jian ChenDirector, since 2024
- Mr. Jun JiangDirector, since 2020CN¥2.0m
- Mr. Chang'an XuDirector
- Mr. Tian YangDirector
- Ms. Hua ChengIndependent DirectorCN¥150,000
- Ms. Lingli HanIndependent DirectorCN¥150,000
- Mr. Li MaIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 23
- Environment
- 12
- Social
- 12
- Governance
- 45
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Xiangcai Co Ltd's real estate business develops residential and industrial properties in Harbin, China.
- Xiangcai Co Ltd produces soybean protein isolate and tissue protein for deep processing.
- Xiangcai Co Ltd manufactures waterproof membranes for construction applications.
Weaknesses
- Xiangcai Co Ltd's pharmaceutical business focuses on thymopeptide enteric-coated tablets only.
- Xiangcai Co Ltd's soybean processing business lacks non-GMO product diversification.
- Xiangcai Co Ltd's waterproof membrane business is limited to specific coil types.
Opportunities
- Xiangcai Co Ltd can expand its real estate development into other Chinese cities.
- Xiangcai Co Ltd can increase its non-GMO soybean product line in the market.
- Xiangcai Co Ltd can grow its pharmaceutical business with new drug development.
Threats
- Xiangcai Co Ltd faces competition from other real estate developers in Harbin.
- Xiangcai Co Ltd's waterproof membrane business is vulnerable to material cost fluctuations.
- Xiangcai Co Ltd's pharmaceutical business is subject to regulatory changes in China.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.